Brand Name Ferox
Type IV Injection or Infusion
Weight 750 mg/15 ml
Generic Ferric Carboxymaltose
Manufacturer ACI Limited
Price (Bangladesh) 15 ml vial: ৳ 1,000.00
Available in

About Ferox IV Injection or Infusion 750 mg/15 ml

Ferox IV Injection or Infusion 750 mg/15 ml is a brand medicine manufactured by ACI Limited containing the generic Ferric Carboxymaltose (750 mg/15 ml). Current listed price in Bangladesh: 15 ml vial: ৳ 1,000.00.

Medical information for Ferox IV Injection or Infusion 750 mg/15 ml

Uses, dosage, side effects, and safety details below apply to Ferox IV Injection or Infusion 750 mg/15 ml (generic: Ferric Carboxymaltose). This is general information — consult a doctor before use.

Introduction

Ferox IV Injection or Infusion 750 mg/15 ml is an iron replacement product and chemically, an iron carbohydrate complex. FDA approved on July 25, 2013.

Uses

Ferric carboxymaltose is an iron replacement therapy used to treat iron deficiency anemia in adults with intolerance or inadequate clinical response to oral iron or those who have non-dialysis dependent chronic kidney disease.

Ferric carboxymaltose is a iron replacement product indicated for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron or those who have non-dialysis dependent chronic kidney disease.

Associated Conditions

  • Iron Deficiency Anemia (IDA)

Pharmacodynamics

When measured using positron emission tomography (PET), the red cell uptake of 59-Fe and 52-Fe from INJECTAFER ranged from 61% to 99%. In patients with iron deficiency, the red cell uptake ranged from 91% to 99%. In patients with renal anemia, the red cell uptake ranged from 61% to 84%.

Mechanism of Action

Ferric carboxymaltose is a colloidal iron (III) hydroxide in complex with carboxymaltose, a carbohydrate polymer that release iron.

Absorption

When a single dose of 100 to 1000 mg of iron was given to iron deficient patients, the maximum serum concentration (Cmax) was 37 μg/mL to 333 μg/mL. These levels were obtained 15 minutes to 1.21 hours post dose (Tmax).

Volume of Distribution

3 L

Route of Elimination

Renal elimination of iron was negligible.

Half Life

7 to 12 hours.

Toxicity

The most common adverse reactions (>2%) are nausea, hypertension, flushing, hypophosphatemia, and dizziness.

Food Interactions

No interactions found.

Dosage

The posology of Ferox IV Injection or Infusion 750 mg/15 ml follows a stepwise approach:
  1. determination of the individual iron need
  2. calculation and administration of the iron dose(s)
  3. post-iron repletion assessments.
Step 1: Determination of the iron need: The individual iron need for repletion using Fematos is determined based on the patient's body weight and haemoglobin (Hb) level. The following list for determination of the iron need:

Hb <10 g/dl
  • below 35 kg: 500 mg
  • 35 kg to <70 kg: 1500 mg
  • 70 kg and over: 2000 mg
Hb 10 to 14 g/dl
  • below 35 kg: 500 mg
  • 35 kg to <70 kg: 1000 mg
  • 70 kg and over: 1500 mg
Hb >14 g/dl
  • below 35 kg: 500 mg
  • 35 kg to <70 kg: 500 mg
  • 70 kg and over: 500 mg
Step 2: Calculation and administration of the maximum individual iron dose(s): Based on the iron need determined above the appropriate dose(s) of Ferox IV Injection or Infusion 750 mg/15 ml should be administered taking into consideration the following:

A single Ferox IV Injection or Infusion 750 mg/15 ml administration should not exceed:
  • 15 mg iron/kg body weight (for administration by intravenous injection) or 20 mg iron/kg body weight (for administration by intravenous infusion)
  • 1,000 mg of iron (20 ml Ferox IV Injection or Infusion 750 mg/15 ml)
  • The maximum recommended cumulative dose of Ferox IV Injection or Infusion 750 mg/15 ml is 1000 mg of iron per week.
Step 3: Post-iron repletion assessments: Re-assessment should be performed by the clinician based on the individual patient's condition. The Hb level should be re-assessed no earlier than 4 weeks post final Ferox IV Injection or Infusion 750 mg/15 ml administration to allow adequate time for erythropoiesis and iron utilisation. In the event the patient requires further iron repletion, the iron need should be recalculated using above list.

Medical review

Last reviewed: 24 Jul 2026

Medically reviewed by:

This is general information, not personal medical advice. Consult a doctor before taking any medicine.

Taking medicines without doctor's advice can cause long-term problems.
Dr. Ali Asgar Chowdhury

Dr. Ali Asgar Chowdhury

Cancer & Tumor Specialist

Call Doctor
Dr. Nayem Hasan

Dr. Nayem Hasan

Medicine Specialist

Call Doctor
Dr. Provati Pandit

Dr. Provati Pandit

Child & Child Neurology Specialist

Call Doctor
Related Medicines